Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
REVB · NASDAQ · Pharmaceutical Preparations
$3.50−0.19 (−5.15%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Revelation Biosciences (REVB) · oqro.io/stocks/REVB · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
No fund moves found
Nothing has been reported for this company in this source yet.
Funds reporting a stake
2
$47K in total
Shares held by these funds
42K
Reports dated May 31, 2026 to Jun 30, 2026
Change vs each fund's previous report
+15K shares
1 added
Every mutual fund and ETF files an N-PORT report; the one for the last month of each fiscal quarter is made public about 60 days later. Funds have different quarter ends, so their dates differ. Funds can hold each other, and many index funds also show up in their manager's 13F, so these figures overlap with the 13F section.
Source: SEC Form N-PORT data set, filings made Jul to Sep 2026; change compared with each fund's previous public report. Long common stock only (short positions, options and bonds left out), every line of a fund for the stock added up, values in US dollars as filed. 2 funds in total; the 2 largest by value are listed.
None of the 31 ETFs OQRO follows reported REVB in its latest N-PORT report.
Source: each ETF’s latest SEC Form N-PORT report. Vanguard ETFs are share classes of larger funds, so their figures are the whole fund’s.
Institutions reporting a stake, Q2 2026
11
+0 vs Q1 2026
Share of stock reported
44.5%
304K of 683K shares outstanding
Change vs Q1 2026
-195K shares
3 new positions, 3 positions closed
Reported in 13F filings, which cover managers over $100M and include double counting. A 13F shows holdings on the last day of the quarter, not when shares were bought or sold. Change counts the 11 managers that reported both quarters.
Source: SEC Form 13F data sets, every filer, common stock only (options and bonds left out). Amendments are applied; lines whose value was filed in thousands are scaled, and lines whose shares and value disagree are left out.